Would Payers be Willing to Prefer Steglaro to Provide a More Affordable Medicare Option?
P&T Session Heart Failure: MMIT recently conducted a syndicated simulated P&T Heart Failure session focused on the entry Farxiga, and anticipated entry of Jardiance, into heart failure.
© 2024 MMIT